These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13713709)

  • 1. [A new antiserotonin agent in the treatment of asthma, headache, urticaria, severe colitis and rheumatic diseases].
    HERRAIZ BALLESTERO L; SIMKIN ZMUD B
    Prensa Med Argent; 1961 Jan; 48():89-93. PubMed ID: 13713709
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.
    CERLETTI A; DOEPFNER W
    J Pharmacol Exp Ther; 1958 Jan; 122(1):124-36. PubMed ID: 13502837
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 5. On migraine headache: serotonin and serotonin antagonism.
    DALESSIO DJ
    JAMA; 1962 Jul; 181():318-21. PubMed ID: 13883200
    [No Abstract]   [Full Text] [Related]  

  • 6. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the treatment of headache with Deseril].
    BRZECKI A
    Pol Tyg Lek; 1962 Mar; 17():440-2. PubMed ID: 13874157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of bronchial asthma with Methisergid (UML-491), a new antiserotonin drug].
    TORRES-ACERO FERNANDEZ JM
    Med Clin (Barc); 1962 Nov; 39():361-3. PubMed ID: 13993728
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
    ROOKE ED; RUSHTON JG; PETERS GA
    Proc Staff Meet Mayo Clin; 1962 Aug; 37():433-43. PubMed ID: 14493709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysenyl, a new antiserotonin agent. Pharmacological and clinical survey.
    Podvalová I; Dlabac A
    Res Clin Stud Headache; 1970; 3():325-34. PubMed ID: 5527212
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of posttraumatic headache with a serotonin antagonist].
    BITTER T
    Rev Bras Med; 1962 Sep; 19():543-4. PubMed ID: 13971269
    [No Abstract]   [Full Text] [Related]  

  • 14. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.
    Karst M; Halpern JH; Bernateck M; Passie T
    Cephalalgia; 2010 Sep; 30(9):1140-4. PubMed ID: 20713566
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of a serotonin antagonist on rheumatic inflammation].
    GARELLI R
    Reumatismo; 1960; 12():92-8. PubMed ID: 13703641
    [No Abstract]   [Full Text] [Related]  

  • 18. The antiserotonin properties of benzcyclane.
    Dávid G; Kenedi I
    Acta Physiol Acad Sci Hung; 1968; 34(1):123-7. PubMed ID: 5705050
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations of the clinical trial of tropin-4-chlorobenzhydryl ether hydrochloride.
    DUTTON LO; HALPIN L
    Ann Allergy; 1955; 13(1):104-8. PubMed ID: 14362238
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of urticaria and severe headache by behavior therapy. A case study.
    Daniels LK
    Psychosomatics; 1973; 14(6):347-51. PubMed ID: 4795140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.